Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ESR1 | P03372 | 3/20 | 0.48 |
| ▸ | ESR2 | Q92731 | 3/20 | 0.48 |
| ▸ | CYP11B1 | P15538 | 2/20 | 0.45 |
| ▸ | CYP11B2 | P19099 | 2/20 | 0.45 |
| ▸ | CYP17A1 | P05093 | 1/20 | 0.44 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.44 |
| ▸ | CLK4 | Q9HAZ1 | 2/20 | 0.44 |
| ▸ | MAP4K4 | O95819 | 1/20 | 0.44 |
| ▸ | TYK2 | P29597 | 1/20 | 0.44 |
| ▸ | MINK1 | Q8N4C8 | 1/20 | 0.44 |
| ▸ | SRPK1 | Q96SB4 | 1/20 | 0.44 |
| ▸ | BACE1 | P56817 | 1/20 | 0.43 |
| ▸ | FGFR1 | P11362 | 1/20 | 0.43 |
| ▸ | DYRK3 | O43781 | 1/20 | 0.43 |
| ▸ | CLK1 | P49759 | 1/20 | 0.43 |
| ▸ | CLK2 | P49760 | 1/20 | 0.43 |
| ▸ | CLK3 | P49761 | 1/20 | 0.43 |
| ▸ | GSK3B | P49841 | 1/20 | 0.43 |
| ▸ | CDK5 | Q00535 | 1/20 | 0.43 |
| ▸ | DYRK1A | Q13627 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23705771 | 0.93 | CLK4 (0.51) | ESR1ESR2CYP11B1CYP11B2CYP17A1 | |
| SCHEMBL14244848 | 0.78 | PDPK1 (0.62) | ESR1ESR2CYP11B1CYP11B2CYP17A1 | |
| SCHEMBL16905443 | 0.78 | CYP1A2 (0.62) | ESR1ESR2CYP11B1CYP11B2CYP17A1 | |
| SCHEMBL239390 | 0.78 | CYP2A6 (0.54) | NPC1RAB9A | |
| SCHEMBL30502940 | 0.78 | CYP2A6 (0.54) | NPC1RAB9A | |
| SCHEMBL30304006 | 0.77 | ESR1 (0.73) | ESR1ESR2CYP11B1CYP11B2CYP17A1 | |
| SCHEMBL16107069 | 0.77 | ESR1 (0.73) | ESR1ESR2CYP11B1CYP11B2CYP17A1 | |
| SCHEMBL16968057 | 0.76 | DYRK1A (0.52) | CYP19A1CLK4MAP4K4TYK2CLK1 | |
| SCHEMBL15618458 | 0.76 | HSD17B1 (0.54) | CYP11B1CYP11B2CYP17A1CYP19A1NPC1 | |
| SCHEMBL15507438 | 0.76 | CYP2A6 (0.62) | CYP11B1CYP11B2CYP17A1CYP19A1CLK4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260076027-A1 | HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING SAME | LT MATERIALS CO LTD (KR) | 2026-03-12 | — | — | US | disclosed |
| EP-4707356-A1 | HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING SAME | LT Materials Co., Ltd. (KR) | 2026-03-11 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260076027-A1 | HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING SAME | CRY1, CYC1, CRY2 | ESR1 314/4885ESR2 765/4885CYP11B1 163/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.